{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:03:28Z","timestamp":1790496208705,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,6,20]],"date-time":"2008-06-20T00:00:00Z","timestamp":1213920000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s10585-008-9187-x","type":"journal-article","created":{"date-parts":[[2008,6,19]],"date-time":"2008-06-19T10:20:40Z","timestamp":1213870840000},"page":"753-763","source":"Crossref","is-referenced-by-count":46,"title":["Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer"],"prefix":"10.1007","volume":"25","author":[{"given":"Brandon J.","family":"Metge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andra R.","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy A.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna Lynn","family":"Dyess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny R.","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev S.","family":"Samant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalita A.","family":"Shevde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,6,20]]},"reference":[{"key":"9187_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(03)00304-5","volume":"198","author":"LA Shevde","year":"2003","unstructured":"Shevde LA, Welch DR (2003) Metastasis suppressor pathways\u2014an evolving paradigm. Cancer Lett 198:1\u201320. doi: 10.1016\/S0304-3835(03)00304-5","journal-title":"Cancer Lett"},{"key":"9187_CR2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1023\/A:1013124725690","volume":"18","author":"RS Samant","year":"2000","unstructured":"Samant RS, Seraj MJ, Saunders MM, Sakamaki TS, Shevde LA, Harms JF et al (2000) Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clin Exp Metastasis 18:683\u2013693. doi: 10.1023\/A:1013124725690","journal-title":"Clin Exp Metastasis"},{"key":"9187_CR3","first-page":"2764","volume":"60","author":"MJ Seraj","year":"2000","unstructured":"Seraj MJ, Samant RS, Verderame MF, Welch DR (2000) Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res 60:2764\u20132769","journal-title":"Cancer Res"},{"key":"9187_CR4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ijc.1569","volume":"97","author":"RS Samant","year":"2002","unstructured":"Samant RS, Debies MT, Shevde LA, Verderame MF, Welch DR (2002) Identification and characterization of the murine ortholog (brms1) of breast-cancer metastasis suppressor 1 (BRMS1). Int J Cancer 97:15\u201320. doi: 10.1002\/ijc.1569","journal-title":"Int J Cancer"},{"key":"9187_CR5","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1158\/1078-0432.CCR-06-1347","volume":"12","author":"Z Zhang","year":"2006","unstructured":"Zhang Z, Yamashita H, Toyama T, Yamamoto Y, Kawasoe T, Iwase H (2006) Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer. Clin Cancer Res 12:6410\u20136414. doi: 10.1158\/1078-0432.CCR-06-1347","journal-title":"Clin Cancer Res"},{"key":"9187_CR6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00432-004-0629-9","volume":"131","author":"AM Stark","year":"2005","unstructured":"Stark AM, Tongers K, Maass N, Mehdorn HM, Held-Feindt J (2005) Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. J Cancer Res Clin Oncol 131:191\u2013198. doi: 10.1007\/s00432-004-0629-9","journal-title":"J Cancer Res Clin Oncol"},{"key":"9187_CR7","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.1158\/1078-0432.CCR-06-0635","volume":"12","author":"DG Hicks","year":"2006","unstructured":"Hicks DG, Yoder BJ, Short S, Tarr S, Prescott N, Crowe JP et al (2006) Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patients. Clin Cancer Res 12:6702\u20136708. doi: 10.1158\/1078-0432.CCR-06-0635","journal-title":"Clin Cancer Res"},{"key":"9187_CR8","first-page":"1765","volume":"61","author":"MM Saunders","year":"2001","unstructured":"Saunders MM, Seraj MJ, Li Z, Zhou Z, Winter CR, Welch DR et al (2001) Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res 61:1765\u20131767","journal-title":"Cancer Res"},{"key":"9187_CR9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/excr.2001.5452","volume":"273","author":"LA Shevde","year":"2002","unstructured":"Shevde LA, Samant RS, Goldberg SF, Sikaneta T, Alessandrini A, Donahue HJ et al (2002) Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. Exp Cell Res 273:229\u2013239. doi: 10.1006\/excr.2001.5452","journal-title":"Exp Cell Res"},{"key":"9187_CR10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1158\/0008-5472.713.65.3","volume":"65","author":"DB DeWald","year":"2005","unstructured":"DeWald DB, Torabinejad J, Samant RS, Johnston D, Erin N, Shope JC et al (2005) Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells. Cancer Res 65:713\u2013717","journal-title":"Cancer Res"},{"key":"9187_CR11","doi-asserted-by":"crossref","first-page":"8683","DOI":"10.1128\/MCB.00940-06","volume":"26","author":"Y Liu","year":"2006","unstructured":"Liu Y, Smith PW, Jones DR (2006) Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA\/p65 and promoting apoptosis. Mol Cell Biol 26:8683\u20138696. doi: 10.1128\/MCB.00940-06","journal-title":"Mol Cell Biol"},{"key":"9187_CR12","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1158\/0008-5472.CAN-04-3139","volume":"65","author":"M Cicek","year":"2005","unstructured":"Cicek M, Fukuyama R, Welch DR, Sizemore N, Casey G (2005) Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity. Cancer Res 65:3586\u20133595. doi: 10.1158\/0008-5472.CAN-04-3139","journal-title":"Cancer Res"},{"key":"9187_CR13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-4598-6-6","volume":"6","author":"RS Samant","year":"2007","unstructured":"Samant RS, Clark DW, Fillmore RA, Cicek M, Metge BJ, Chandramouli KH et al (2007) Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation. Mol Cancer 6:6. doi: 10.1186\/1476-4598-6-6","journal-title":"Mol Cancer"},{"key":"9187_CR14","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.bbrc.2006.08.005","volume":"348","author":"DR Hurst","year":"2006","unstructured":"Hurst DR, Mehta A, Moore BP, Phadke PA, Meehan WJ, Accavitti MA et al (2006) Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone. Biochem Biophys Res Commun 348:1429\u20131435. doi: 10.1016\/j.bbrc.2006.08.005","journal-title":"Biochem Biophys Res Commun"},{"key":"9187_CR15","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1074\/jbc.M307969200","volume":"279","author":"WJ Meehan","year":"2004","unstructured":"Meehan WJ, Samant RS, Hopper JE, Carrozza MJ, Shevde LA, Workman JL et al (2004) Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. J Biol Chem 279:1562\u20131569. doi: 10.1074\/jbc.M307969200","journal-title":"J Biol Chem"},{"key":"9187_CR16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10585-007-9092-8","volume":"24","author":"PJ Champine","year":"2007","unstructured":"Champine PJ, Michaelson J, Weimer BC, Welch DR, Dewald DB (2007) Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression. Clin Exp Metastasis 24:551\u2013565. doi: 10.1007\/s10585-007-9092-8","journal-title":"Clin Exp Metastasis"},{"key":"9187_CR17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/B:CLIN.0000024729.19084.f0","volume":"21","author":"M Cicek","year":"2004","unstructured":"Cicek M, Samant RS, Kinter M, Welch DR, Casey G (2004) Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells. Clin Exp Metastasis 21:149\u2013157. doi: 10.1023\/B:CLIN.0000024729.19084.f0","journal-title":"Clin Exp Metastasis"},{"key":"9187_CR18","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1021\/pr0703167","volume":"6","author":"J Rivera","year":"2007","unstructured":"Rivera J, Megias D, Bravo J (2007) Proteomics-based strategy to delineate the molecular mechanisms of the metastasis suppressor gene BRMS1. J Proteome Res 6:4006\u20134018","journal-title":"J Proteome Res"},{"key":"9187_CR19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1006461422273","volume":"65","author":"SJ Santner","year":"2001","unstructured":"Santner SJ, Dawson PJ, Tait L, Soule HD, Eliason J, Mohamed AN et al (2001) Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat 65:101\u2013110. doi: 10.1023\/A:1006461422273","journal-title":"Breast Cancer Res Treat"},{"key":"9187_CR20","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/jnci\/92.14.1185a","volume":"92","author":"FR Miller","year":"2000","unstructured":"Miller FR, Santner SJ, Tait L, Dawson PJ (2000) MCF10DCIS.com xenograft model of human comedo ductal carcinoma in\u00a0situ. J Natl Cancer Inst 92:1185\u20131186. doi: 10.1093\/jnci\/92.14.1185A","journal-title":"J Natl Cancer Inst"},{"key":"9187_CR21","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/mp.55.5.294","volume":"55","author":"G Ellison","year":"2002","unstructured":"Ellison G, Klinowska T, Westwood RF, Docter E, French T, Fox JC (2002) Further evidence to support the melanocytic origin of MDA-MB-435. Mol Pathol 55:294\u2013299. doi: 10.1136\/mp. 55.5.294","journal-title":"Mol Pathol"},{"key":"9187_CR22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10585-004-3759-1","volume":"21","author":"JM Rae","year":"2004","unstructured":"Rae JM, Ramus SJ, Waltham M, Armes JE, Campbell IG, Clarke R et al (2004) Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties. Clin Exp Metastasis 21:543\u2013552. doi: 10.1007\/s10585-004-3759-1","journal-title":"Clin Exp Metastasis"},{"key":"9187_CR23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-006-9392-8","volume":"104","author":"JM Rae","year":"2007","unstructured":"Rae JM, Creighton CJ, Meck JM, Haddad BR, Johnson MD (2007) MDA-MB-435 cells are derived from M14 melanoma cells\u2013a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res Treat 104:13\u201319. doi: 10.1007\/s10549-006-9392-8","journal-title":"Breast Cancer Res Treat"},{"key":"9187_CR24","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.4161\/cbt.6.9.4624","volume":"6","author":"M Christgen","year":"2007","unstructured":"Christgen M, Lehmann U (2007) MDA-MB-435: the questionable use of a melanoma cell line as a model for human breast cancer is ongoing. Cancer Biol Ther 6:1355\u20131357","journal-title":"Cancer Biol Ther"},{"key":"9187_CR25","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1158\/0008-5472.CAN-3299-2","volume":"64","author":"S Sellappan","year":"2004","unstructured":"Sellappan S, Grijalva R, Zhou X, Yang W, Eli MB, Mills GB et al (2004) Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line. Cancer Res 64:3479\u20133485. doi: 10.1158\/0008-5472.CAN-3299-2","journal-title":"Cancer Res"},{"key":"9187_CR26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1023\/A:1018477516367","volume":"15","author":"DR Welch","year":"1997","unstructured":"Welch DR (1997) Technical considerations for studying cancer metastasis in\u00a0vivo. Clin Exp Metastasis 15:272\u2013306. doi: 10.1023\/A:1018477516367","journal-title":"Clin Exp Metastasis"},{"issue":"12","key":"9187_CR27","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1074\/jbc.M709446200","volume":"283","author":"DR Hurst","year":"2008","unstructured":"Hurst DR, Xie Y, Vaidya KS, Mehta A, Moore BP, Accavitti-Loper MA, Samant RS, Saxena R, Silveira AC, Welch DR (2008) Alterations of breast cancer metastasis suppressor 1:At rich interactive domain 4A interaction modify gene expression but still suppress metastasis in human breast cancer cells. J Biol Chem 283(12):7438\u20137444","journal-title":"J Biol Chem"},{"key":"9187_CR28","first-page":"235","volume":"3","author":"D Takai","year":"2003","unstructured":"Takai D, Jones PA (2003) The CpG island searcher: a new WWW resource. In\u00a0Silico Biol 3:235\u2013240","journal-title":"In\u00a0Silico Biol"},{"key":"9187_CR29","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/bioinformatics\/18.11.1427","volume":"18","author":"LC Li","year":"2002","unstructured":"Li LC, Dahiya R (2002) MethPrimer: designing primers for methylation PCRs. Bioinformatics (Oxford, England) 18:1427\u20131431. doi: 10.1093\/bioinformatics\/18.11.1427","journal-title":"Bioinformatics (Oxford, England)"},{"key":"9187_CR30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10585-006-9013-2","volume":"23","author":"LA Shevde","year":"2006","unstructured":"Shevde LA, Samant RS, Paik JC, Metge BJ, Chambers AF, Casey G et al (2006) Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435. Clin Exp Metastasis 23:123\u2013133. doi: 10.1007\/s10585-006-9013-2","journal-title":"Clin Exp Metastasis"},{"key":"9187_CR31","first-page":"2320","volume":"61","author":"MT Hartsough","year":"2001","unstructured":"Hartsough MT, Clare SE, Mair M, Elkahloun AG, Sgroi D, Osborne CK et al (2001) Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition. Cancer Res 61:2320\u20132327","journal-title":"Cancer Res"},{"key":"9187_CR32","first-page":"921","volume":"61","author":"DM Loeb","year":"2001","unstructured":"Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L et al (2001) Wilms\u2019 tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. Cancer Res 61:921\u2013925","journal-title":"Cancer Res"},{"key":"9187_CR33","first-page":"2782","volume":"61","author":"E Evron","year":"2001","unstructured":"Evron E, Umbricht CB, Korz D, Raman V, Loeb DM, Niranjan B et al (2001) Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res 61:2782\u20132787","journal-title":"Cancer Res"},{"key":"9187_CR34","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1038\/sj.onc.1204438","volume":"20","author":"CB Umbricht","year":"2001","unstructured":"Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S (2001) Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene 20:3348\u20133353. doi: 10.1038\/sj.onc.1204438","journal-title":"Oncogene"},{"key":"9187_CR35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1011306222533","volume":"6","author":"BB Asch","year":"2001","unstructured":"Asch BB, Barcellos-Hoff MH (2001) Epigenetics and breast cancer. J Mammary Gland Biol Neoplasia 6:151\u2013152. doi: 10.1023\/A:1011306222533","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"9187_CR36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1677\/erc.0.0080115","volume":"8","author":"X Yang","year":"2001","unstructured":"Yang X, Yan L, Davidson NE (2001) DNA methylation in breast cancer. Endocr Relat Cancer 8:115\u2013127. doi: 10.1677\/erc.0.0080115","journal-title":"Endocr Relat Cancer"},{"key":"9187_CR37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/mutage\/gem009","volume":"22","author":"FV Jacinto","year":"2007","unstructured":"Jacinto FV, Esteller M (2007) Mutator pathways unleashed by epigenetic silencing in human cancer. Mutagenesis 22:247\u2013253. doi: 10.1093\/mutage\/gem009","journal-title":"Mutagenesis"},{"key":"9187_CR38","first-page":"14","volume":"30","author":"F Jing","year":"2007","unstructured":"Jing F, Zhang J, Tao J, Zhou Y, Jun L, Tang X et al (2007) Hypermethylation of tumor suppressor genes BRCA1, p16 and 14-3-3sigma in serum of sporadic breast cancer patients. Onkologie 30:14\u201319. doi: 10.1159\/000096892","journal-title":"Onkologie"},{"key":"9187_CR39","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1158\/1078-0432.CCR-03-0652","volume":"10","author":"L Cheng","year":"2004","unstructured":"Cheng L, Pan CX, Zhang JT, Zhang S, Kinch MS, Li L et al (2004) Loss of 14-3-3sigma in prostate cancer and its precursors. Clin Cancer Res 10:3064\u20133068. doi: 10.1158\/1078-0432.CCR-03-0652","journal-title":"Clin Cancer Res"},{"key":"9187_CR40","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1089\/dna.2005.24.264","volume":"24","author":"R Henrique","year":"2005","unstructured":"Henrique R, Jeronimo C, Hoque MO, Carvalho AL, Oliveira J, Teixeira MR et al (2005) Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions. DNA Cell Biol 24:264\u2013269. doi: 10.1089\/dna.2005.24.264","journal-title":"DNA Cell Biol"},{"key":"9187_CR41","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1073\/pnas.100566997","volume":"97","author":"AT Ferguson","year":"2000","unstructured":"Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H et al (2000) High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA 97:6049\u20136054. doi: 10.1073\/pnas.100566997","journal-title":"Proc Natl Acad Sci USA"},{"key":"9187_CR42","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1038\/sj.onc.1203898","volume":"19","author":"N Iwata","year":"2000","unstructured":"Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T et al (2000) Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Oncogene 19:5298\u20135302. doi: 10.1038\/sj.onc.1203898","journal-title":"Oncogene"},{"key":"9187_CR43","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1038\/sj.onc.1205303","volume":"21","author":"H Osada","year":"2002","unstructured":"Osada H, Tatematsu Y, Yatabe Y, Nakagawa T, Konishi H, Harano T et al (2002) Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers. Oncogene 21:2418\u20132424. doi: 10.1038\/sj.onc.1205303","journal-title":"Oncogene"},{"key":"9187_CR44","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.bbrc.2004.02.171","volume":"316","author":"M Kaneuchi","year":"2004","unstructured":"Kaneuchi M, Sasaki M, Tanaka Y, Shiina H, Verma M, Ebina Y et al (2004) Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer. Biochem Biophys Res Commun 316:1156\u20131162. doi: 10.1016\/j.bbrc.2004.02.171","journal-title":"Biochem Biophys Res Commun"},{"key":"9187_CR45","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/ijc.22379","volume":"120","author":"G Lombardi","year":"2007","unstructured":"Lombardi G, Di Cristofano C, Capodanno A, Iorio MC, Aretini P, Isola P et al (2007) High level of messenger RNA for BRMS1 in primary breast carcinomas is associated with poor prognosis. Int J Cancer 120:1169\u20131178. doi: 10.1002\/ijc.22379","journal-title":"Int J Cancer"},{"key":"9187_CR46","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000086955","volume":"26","author":"LM Kelly","year":"2005","unstructured":"Kelly LM, Buggy Y, Hill A, O\u2032Donovan N, Duggan C, McDermott EW et al (2005) Expression of the breast cancer metastasis suppressor gene, BRMS1, in human breast carcinoma: lack of correlation with metastasis to axillary lymph nodes. Tumour Biol 26:213\u2013216. doi: 10.1159\/000086955","journal-title":"Tumour Biol"},{"key":"9187_CR47","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1074\/jbc.274.8.4504","volume":"274","author":"T Schwientek","year":"1999","unstructured":"Schwientek T, Nomoto M, Levery SB, Merkx G, van Kessel AG, Bennett EP et al (1999) Control of O-glycan branch formation. Molecular cloning of human cDNA encoding a novel beta1, 6-N-acetylglucosaminyltransferase forming core 2 and core 4. J Biol Chem 274:4504\u20134512. doi: 10.1074\/jbc.274.8.4504","journal-title":"J Biol Chem"},{"key":"9187_CR48","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1158\/1078-0432.CCR-06-0800","volume":"12","author":"IG Campbell","year":"2006","unstructured":"Campbell IG, Phillips WA, Choong DY (2006) Genetic and epigenetic analysis of the putative tumor suppressor km23 in primary ovarian, breast, and colorectal cancers. Clin Cancer Res 12:3713\u20133715. doi: 10.1158\/1078-0432.CCR-06-0800","journal-title":"Clin Cancer Res"},{"key":"9187_CR49","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.leukres.2005.07.012","volume":"30","author":"F Gumy-Pause","year":"2006","unstructured":"Gumy-Pause F, Wacker P, Maillet P, Betts DR, Sappino AP (2006) ATM promoter analysis in childhood lymphoid malignancies: a brief communication. Leuk Res 30:335\u2013337. doi: 10.1016\/j.leukres.2005.07.012","journal-title":"Leuk Res"},{"key":"9187_CR50","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1158\/1078-0432.1146.11.3","volume":"11","author":"S Alvarez","year":"2005","unstructured":"Alvarez S, Diaz-Uriarte R, Osorio A, Barroso A, Melchor L, Paz MF et al (2005) A predictor based on the somatic genomic changes of the BRCA1\/BRCA2 breast cancer tumors identifies the non-BRCA1\/BRCA2 tumors with BRCA1 promoter hypermethylation. Clin Cancer Res 11:1146\u20131153","journal-title":"Clin Cancer Res"},{"key":"9187_CR51","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1038\/sj.onc.1205528","volume":"21","author":"M Hasegawa","year":"2002","unstructured":"Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M, Kelsey KT (2002) Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene 21:4231\u20134236. doi: 10.1038\/sj.onc.1205528","journal-title":"Oncogene"},{"key":"9187_CR52","unstructured":"Lu R, Fang JY, Zhu HY, Chen YX, Cheng ZH, Li EL (2004) Effect of eukaryotic expression plasmid DNA methyltransferase gene on methylation status and transcription level of DNA mismatch repair genes in human colon cancer cell line. Zhonghua Yi Xue Za Zhi 84:1014\u20131017"},{"key":"9187_CR53","first-page":"201","volume":"29","author":"L Wang","year":"2006","unstructured":"Wang L, Wang J, Sun S, Rodriguez M, Yue P, Jang SJ et al (2006) A novel DNMT3B subfamily, DeltaDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancer. Int J Oncol 29:201\u2013207","journal-title":"Int J Oncol"},{"key":"9187_CR54","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0959-437X(93)90027-M","volume":"3","author":"PH Tate","year":"1993","unstructured":"Tate PH, Bird AP (1993) Effects of DNA methylation on DNA-binding proteins and gene expression. Curr Opin Genet Dev 3:226\u2013231. doi: 10.1016\/0959-437X(93)90027-M","journal-title":"Curr Opin Genet Dev"},{"key":"9187_CR55","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1038\/sj.onc.1205581","volume":"21","author":"M Sato","year":"2002","unstructured":"Sato M, Horio Y, Sekido Y, Minna JD, Shimokata K, Hasegawa Y (2002) The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Oncogene 21:4822\u20134829. doi: 10.1038\/sj.onc.1205581","journal-title":"Oncogene"},{"key":"9187_CR56","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cccn.2004.07.006","volume":"349","author":"Y Gao","year":"2004","unstructured":"Gao Y, Guan M, Su B, Liu W, Xu M, Lu Y (2004) Hypermethylation of the RASSF1A gene in gliomas. Clin Chim Acta 349:173\u2013179. doi: 10.1016\/j.cccn.2004.07.006","journal-title":"Clin Chim Acta"},{"key":"9187_CR57","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.3748\/wjg.v10.i23.3394","volume":"10","author":"JY Fang","year":"2004","unstructured":"Fang JY, Cheng ZH, Chen YX, Lu R, Yang L, Zhu HY et al (2004) Expression of Dnmt1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer. World J Gastroenterol 10:3394\u20133398","journal-title":"World J Gastroenterol"},{"key":"9187_CR58","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3816\/CBC.2003.n.012","volume":"4","author":"PS Steeg","year":"2003","unstructured":"Steeg PS, Ouatas T, Halverson D, Palmieri D, Salerno M (2003) Metastasis suppressor genes: basic biology and potential clinical use. Clin Breast Cancer 4:51\u201362","journal-title":"Clin Breast Cancer"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-008-9187-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-008-9187-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-008-9187-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T12:51:43Z","timestamp":1709038303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-008-9187-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,20]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["9187"],"URL":"https:\/\/doi.org\/10.1007\/s10585-008-9187-x","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,20]]}}}